THE DEVELOPMENT OF A SIMPLE EMPIRICAL SCORING FUNCTION TO ESTIMATE THE BINDING CONSTANT FOR A PROTEIN LIGAND COMPLEX OF KNOWN 3-DIMENSIONAL STRUCTURE

被引:868
作者
BOHM, HJ
机构
[1] Central Research, BASF AG, Ludwigshafen
关键词
PROTEINS; PROTEIN-LIGAND INTERACTION; DE NOVO DESIGN; SCORING FUNCTION;
D O I
10.1007/BF00126743
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A new simple empirical function has been developed that estimates the free energy of binding for a given protein-ligand complex of known 3D structure. The function takes into account hydrogen bonds, ionic interactions, the lipophilic protein-ligand contact surface and the number of rotatable bonds in the ligand. The dataset for the calibration of the function consists of 45 protein-ligand complexes. The new energy function reproduces the binding constants (ranging from 2.510(-2) to 4 10(-14) M, corresponding to binding energies between -9 and -76 kJ/mol) of the dataset with a standard deviation of 7.9 kJ/mol, corresponding to 1.4 orders of magnitude in binding affinity. The individual contributions to protein-ligand binding obtained from the scoring function are: ideal neutral hydrogen bond: -4.7 kJ/mol; ideal ionic interaction: -8.3 kJ/mol; lipophilic contact: -0.17 kJ/mol Angstrom(2); One rotatable bond in the ligand: +1.4 kJ/mol. The function also contains a constant contribution (+5.4 kJ/mol) which may be rationalized as loss of translational and rotational entropy. The function can be evaluated very fast and is therefore also suitable for application in a 3D database search or de novo ligand design program such as LUDI.
引用
收藏
页码:243 / 256
页数:14
相关论文
共 70 条
[1]   FUNCTIONAL-GROUP CONTRIBUTIONS TO DRUG RECEPTOR INTERACTIONS [J].
ANDREWS, PR ;
CRAIK, DJ ;
MARTIN, JL .
JOURNAL OF MEDICINAL CHEMISTRY, 1984, 27 (12) :1648-1657
[2]  
[Anonymous], HDB ENZYME INHIBITOR
[3]  
APPELT K, 1991, J MED CHEM, V34, P1834
[4]   STRUCTURAL-ANALYSIS OF A SERIES OF ANTIVIRAL AGENTS COMPLEXED WITH HUMAN RHINOVIRUS-14 [J].
BADGER, J ;
MINOR, I ;
KREMER, MJ ;
OLIVEIRA, MA ;
SMITH, TJ ;
GRIFFITH, JP ;
GUERIN, DMA ;
KRISHNASWAMY, S ;
LUO, M ;
ROSSMANN, MG ;
MCKINLAY, MA ;
DIANA, GD ;
DUTKO, FJ ;
FANCHER, M ;
RUECKERT, RR ;
HEINZ, BA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (10) :3304-3308
[5]   IRREVERSIBLE ENZYME INHIBITORS .106. PROTEOLYTIC ENZYMES .I. BULK TOLERANCES IN TRYPSIN-INHIBITOR COMPLEXES [J].
BAKER, BR ;
ERICKSON, EH .
JOURNAL OF MEDICINAL CHEMISTRY, 1967, 10 (06) :1123-+
[6]   PROTEIN DATA BANK - COMPUTER-BASED ARCHIVAL FILE FOR MACROMOLECULAR STRUCTURES [J].
BERNSTEIN, FC ;
KOETZLE, TF ;
WILLIAMS, GJB ;
MEYER, EF ;
BRICE, MD ;
RODGERS, JR ;
KENNARD, O ;
SHIMANOUCHI, T ;
TASUMI, M .
JOURNAL OF MOLECULAR BIOLOGY, 1977, 112 (03) :535-542
[7]   STRUCTURE ACTIVITY RELATIONSHIPS OF DIHYDROFOLATE-REDUCTASE INHIBITORS [J].
BLANEY, JM ;
HANSCH, C ;
SILIPO, C ;
VITTORIA, A .
CHEMICAL REVIEWS, 1984, 84 (04) :333-407
[8]   ON THE RATIONAL DESIGN OF RENIN INHIBITORS - X-RAY STUDIES OF ASPARTIC PROTEINASES COMPLEXED WITH TRANSITION-STATE ANALOGS [J].
BLUNDELL, TL ;
COOPER, J ;
FOUNDLING, SI ;
JONES, DM ;
ATRASH, B ;
SZELKE, M .
BIOCHEMISTRY, 1987, 26 (18) :5585-5590
[9]   GEOMETRY OF BINDING OF THE BENZAMIDINE-BASED AND ARGININE-BASED INHIBITORS N-ALPHA-(2-NAPHTHYL-SULFONYL-GLYCYL)-DL-PARA-AMIDINOPHENYLALANYL-PIPERIDINE (NAPAP) AND (2R,4R)-4-METHYL-1-[N-ALPHA-(3-METHYL-1,2,3,4-TETRAHYDRO-8-QUINOLINESULPHONYL)-L-ARGINYL]-2-PIPERIDINE CARBOXYLIC-ACID (MQPA) TO HUMAN ALPHA-THROMBIN - X-RAY CRYSTALLOGRAPHIC DETERMINATION OF THE NAPAP-TRYPSIN COMPLEX AND MODELING OF NAPAP-THROMBIN AND MQPA-THROMBIN [J].
BODE, W ;
TURK, D ;
STURZEBECHER, J .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1990, 193 (01) :175-182
[10]   DEFINITION AND DISPLAY OF STERIC, HYDROPHOBIC, AND HYDROGEN-BONDING PROPERTIES OF LIGAND-BINDING SITES IN PROTEINS USING LEE AND RICHARDS ACCESSIBLE SURFACE - VALIDATION OF A HIGH-RESOLUTION GRAPHICAL TOOL FOR DRUG DESIGN [J].
BOHACEK, RS ;
MCMARTIN, C .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (10) :1671-1684